AUTHOR=Conchas Grace , Mesfin Yezihalem , He Yuan , Heiller Abigail P. , Lim Hubert H. , Adams Meredith E. , Nelson Peggy 
  
TITLE=Assessment of compliance and satisfaction with a self-adjusting bimodal neuromodulation device and virtual follow-up visits used for tinnitus
  
JOURNAL=Frontiers in Audiology and Otology
  
VOLUME=Volume 4 - 2026
  
YEAR=2026
  
URL=https://www.frontiersin.org/journals/audiology-and-otology/articles/10.3389/fauot.2026.1789957
  
DOI=10.3389/fauot.2026.1789957
  
ISSN=2813-6055
  
ABSTRACT=Tinnitus can negatively impact quality of life for many who experience it, leading to an urgent need for viable treatment options. Tinnitus treatments can vary in quality, validity, and success rates. One method that has shown prior success in clinical trials to reduce the bothersome degree of tinnitus is bimodal neuromodulation, such as with the Lenire treatment device. However, this is not without certain barriers when looking at access to care. Clinicians who treat tinnitus may not be in convenient locations for patients to frequently travel or may not have experience working with people who have tinnitus. One way to reduce this problem, would be to provide fully virtual follow-up sessions, limiting the need for patients to come to clinics. Additionally, another way would be to not “fit” treatment devices based on hearing loss, but to use standard settings for all while allowing suprathreshold adjustments by the user based on comfort. This usability assessment study investigates how making these clinical modifications to the previous Lenire device impacts compliance to the treatment and satisfaction in using the device, as well as tinnitus severity outcome measures. After 12 weeks of device use, compliance and satisfaction remained high as seen in previous studies and many participants had changes that met the level of minimal clinically important difference on tinnitus severity questionnaires. The positive therapeutic outcomes of the study did not differ from previous reports using bimodal neuromodulation for tinnitus, despite simplifying the fitting process for the bimodal neuromodulation treatment, not requiring personalized audiogram settings, and use of virtual follow-up sessions instead of requiring in-person visits. These findings open up opportunities for broader accessibility and scalability of treatment options, such as bimodal neuromodulation, for tinnitus patients.Clinical trial registrationclinicaltrials.gov/study/NCT05518682, identifier: NCT05518682.